Showing results (691-700 of 1,180) with videos related to
Sort By:
Pageof 118
Journal of Pediatric Orthopedics. Part B|February 28, 2017
Pain and overcorrection in clubfeet treated by Ponseti methodChristopher B Hayes, Kevin A Murr, Ryan D Muchow, et al.Carcinogenesis|January 27, 2009
Nitric oxide synthase gene polymorphisms and prostate cancer riskKyoung-Mu Lee, Daehee Kang, Sue Kyung Park, et al.Environmental and Molecular Mutagenesis|June 23, 2007
Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workersLuoping Zhang, Nathaniel Rothman, Guilan Li, et al.The Breast Journal|January 20, 2015
Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery typeTalha Shaikh, Tiffany Y Tam, Tianyu Li, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2014
Do environmental factors modify the genetic risk of prostate cancer?Stacy Loeb, Sarah B Peskoe, Corinne E Joshu, et al.Journal of Pediatric Orthopedics|March 3, 2015
Initial Correction Predicts the Need for Secondary Achilles Tendon Procedures in Patients With Idiopathic Clubfoot Treated With Ponseti CastingPooya Hosseinzadeh, Robert B Steiner, Christopher B Hayes, et al.Journal of Medicinal Chemistry|February 5, 1993
Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonistsF Haviv, T D Fitzpatrick, R E Swenson, et al.Journal of Medicinal Chemistry|October 16, 1992
Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokineticsF Haviy, T D Fitzpatrick, C J Nichols, et al.Toxicologic Pathology|April 5, 2005
Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkersSushil K Thukral, Paul J Nordone, Rong Hu, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1995
No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from ChineseY Sun, A Hildesheim, H Li, et al.Pageof 118